LEXINGTON — Synta Pharmaceuticals Corp. said Thursday that it expects to sell 7 million shares of its stock for about $60 million.
The company priced the offering at $8.60 per share, a penny below its closing price on Wednesday.
To continue getting breaking news and the full stories from The Boston Globe, subscribe today.
LEXINGTON — Synta Pharmaceuticals Corp. said Thursday that it expects to sell 7 million shares of its stock for about $60 million.
The company priced the offering at $8.60 per share, a penny below its closing price on Wednesday.
Comments